tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SLXN Stock Latest News

Buy Rating for Silexion Therapeutics Driven by Promising Preclinical Data and Financial Strength
RatingsBuy Rating for Silexion Therapeutics Driven by Promising Preclinical Data and Financial Strength
6d ago
SLXN
Silexion Therapeutics Enters Inducement Offer Agreement
PremiumCompany Announcements
Silexion Therapeutics Enters Inducement Offer Agreement
7d ago
8K
SLXN
Silexion Therapeutics Corp trading resumes
PremiumThe Fly
Silexion Therapeutics Corp trading resumes
7d ago
SLXN
Silexion Therapeutics Corp trading halted, volatility trading pause
PremiumThe Fly
Silexion Therapeutics Corp trading halted, volatility trading pause
7d ago
SLXN
Silexion Therapeutics Reveals Promising Preclinical Data for SIL204
PremiumCompany Announcements
Silexion Therapeutics Reveals Promising Preclinical Data for SIL204
8d ago
8K
SLXN
Silexion reports data showing up to 90% inhibition of cancer cell growth
PremiumThe FlySilexion reports data showing up to 90% inhibition of cancer cell growth
8d ago
SLXN
Silexion Therapeutics Corp trading resumes
Premium
The Fly
Silexion Therapeutics Corp trading resumes
8d ago
SLXN
Silexion Therapeutics Corp trading halted, volatility trading pause
Premium
The Fly
Silexion Therapeutics Corp trading halted, volatility trading pause
8d ago
SLXN
Silexion Therapeutics Completes Reverse Share Split
PremiumCompany Announcements
Silexion Therapeutics Completes Reverse Share Split
10d ago
8K
SLXN
Silexion Therapeutics Corp trading halted, news pending
PremiumThe Fly
Silexion Therapeutics Corp trading halted, news pending
10d ago
SLXN
Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
12d ago
AGRI
AIHS
Silexion Plans Reverse Split to Regain Nasdaq Compliance
PremiumCompany Announcements
Silexion Plans Reverse Split to Regain Nasdaq Compliance
18d ago
8K
SLXN
Silexion Therapeutics Announces Reverse Share Split Plan
PremiumCompany AnnouncementsSilexion Therapeutics Announces Reverse Share Split Plan
23d ago
8K
SLXN
Silexion Therapeutics announces 1-for-15 reverse share split
Premium
The Fly
Silexion Therapeutics announces 1-for-15 reverse share split
23d ago
SLXN
Silexion Therapeutics Holds Annual General Meeting
Premium
Company Announcements
Silexion Therapeutics Holds Annual General Meeting
25d ago
8K
SLXN
Silexion Announces Positive Preclinical Results for SIL204
PremiumCompany Announcements
Silexion Announces Positive Preclinical Results for SIL204
30d ago
8K
SLXN
Silexion Therapeutics announces results from preclinical study of SIL204
PremiumThe Fly
Silexion Therapeutics announces results from preclinical study of SIL204
30d ago
SLXN
Silexion Therapeutics Stays Listed on Nasdaq After Appeal
PremiumCompany Announcements
Silexion Therapeutics Stays Listed on Nasdaq After Appeal
1M ago
8K
SLXN
Silexion Therapeutics Requests Hearing on Nasdaq Delisting
PremiumCompany Announcements
Silexion Therapeutics Requests Hearing on Nasdaq Delisting
2M ago
8K
SLXN
Promising Future for Silexion Therapeutics: Buy Rating Reiterated Due to SIL-204’s Potential in KRAS-Mutated Cancers
PremiumRatingsPromising Future for Silexion Therapeutics: Buy Rating Reiterated Due to SIL-204’s Potential in KRAS-Mutated Cancers
2M ago
SLXN
Silexion Therapeutics Unveils Promising Preclinical Results for SIL204
Premium
Company Announcements
Silexion Therapeutics Unveils Promising Preclinical Results for SIL204
2M ago
8K
SLXN
Silexion Therapeutics announces preclinical results on SIL204
Premium
The Fly
Silexion Therapeutics announces preclinical results on SIL204
2M ago
SLXN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >